| Name | Title | Contact Details |
|---|---|---|
Jeremiah Hanes |
VP, Reagents R&D | Profile |
Jasmine Pritchard |
Vice President, Product Marketing | Profile |
Alex Nemiroski |
Director of Consumables R&D | Profile |
Natalie Welch |
Vice President Human Resources and Organization Development | Profile |
Alvin Hom |
Head of Global Talent Acquisition | Profile |
Entrada Therapeutics is a biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines, Endosomal Escape Vehicles (EEV™), to engage intracellular targets that have long been considered inaccessible and undruggable. The Company`s EEV therapeutics are designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues with an improved therapeutic index. Through its proprietary, highly versatile and modular EEV Platform, Entrada is building a robust development portfolio of oligonucleotide-, antibody- and enzyme-based programs for the potential treatment of neuromuscular disease, immunology, oncology and diseases of the central nervous system.
Carmot Therapeutics, Inc. is a biotech company focused on the discovery of innovative drugs for the treatment of metabolic diseases, cancer, and inflammation. Carmot`s vision is to become a leader in drug discovery by unlocking novel therapeutic target space not currently accessible to conventional small molecule technologies.
Vaxxinity is a U.S.-based global biotechnology company pioneering a new class of medicines to democratize health.
Spaltudaq Corporation is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Aegerion Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases.